LEP was an unfavorable prognostic marker in cohorts of glioma, lung cancer, colorectal cancer, renal cancer, ovarian cancer, and melanoma, while in patients with thyroid cancer, pancreatic cancer, and breast cancer, high LEP levels were associated with favorable outcomes. The gene discussed is LEP; the disease is melanoma.